Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study.

Conclusions: Treatment with rosuvastatin and sevelamer hydrochloride may not delay the progression of CAC in non-dialysis dependent CKD patients.
PMID: 23442255 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - February 26, 2013 Category: Urology & Nephrology Authors: Lemos MM, Watanabe R, Carvalho AB, Jancikic AD, Sanches FM, Christofalo DM, Draibe SA, Canziani ME Tags: Clin Nephrol Source Type: research